{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:33:51Z","timestamp":1791657231217,"version":"4.3.4"},"reference-count":22,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T00:00:00Z","timestamp":1496966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pathsocjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pathology"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Sinonasal undifferentiated carcinoma (\n                    <jats:styled-content style=\"fixed-case\">SNUC<\/jats:styled-content>\n                    ) is a high\u2010grade malignancy with limited treatment options and poor outcome. A morphological spectrum of 47 sinonasal tumours including 17 (36.2%)\n                    <jats:styled-content style=\"fixed-case\">SNUCs<\/jats:styled-content>\n                    was analysed at genomic level. Thirty carcinomas (cohort 1) were subjected to a hybridization exon\u2010capture next\u2010generation sequencing assay (\n                    <jats:styled-content style=\"fixed-case\">\n                      MSK\u2010IMPACT\n                      <jats:sup>TM<\/jats:sup>\n                    <\/jats:styled-content>\n                    ) to interrogate somatic variants in 279 or 410 cancer\u2010related genes. Seventeen sinonasal tumours (cohort 2) were examined only for the presence of\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">IDH1<\/jats:styled-content>\n                      \/2\n                    <\/jats:italic>\n                    exon 4 mutations by Sanger sequencing.\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">IDH2<\/jats:styled-content>\n                    <\/jats:italic>\n                    <jats:styled-content style=\"fixed-case\">R172<\/jats:styled-content>\n                    single nucleotide variants were overall detected in 14 (82.4%)\n                    <jats:styled-content style=\"fixed-case\">SNUCs<\/jats:styled-content>\n                    , in two (20%) poorly\u2010differentiated carcinomas with glandular\/acinar differentiation, and in one of two high\u2010grade neuroendocrine carcinomas, large cell type (\n                    <jats:styled-content style=\"fixed-case\">HGNECs<\/jats:styled-content>\n                    ). No\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">IDH2<\/jats:styled-content>\n                    <\/jats:italic>\n                    mutation was detected in any of five olfactory neuroblastomas or in any of five\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">SMARCB1<\/jats:styled-content>\n                    <\/jats:italic>\n                    \u2010deficient carcinomas. Among 12\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">IDH2<\/jats:styled-content>\n                    <\/jats:italic>\n                    \u2010mutated cases in cohort 1, five (41.7%) harboured co\u2010existing\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">TP53<\/jats:styled-content>\n                    <\/jats:italic>\n                    mutations, four (33.3%)\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">CDKN2A<\/jats:styled-content>\n                      \/\n                      <jats:styled-content style=\"fixed-case\">2B<\/jats:styled-content>\n                    <\/jats:italic>\n                    loss\u2010of\u2010function alterations, four (33.3%)\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">MYC<\/jats:styled-content>\n                    <\/jats:italic>\n                    amplification, and three (25%) had concurrent\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">SETD2<\/jats:styled-content>\n                    <\/jats:italic>\n                    mutations.\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">AKT1<\/jats:styled-content>\n                    <\/jats:italic>\n                    <jats:styled-content style=\"fixed-case\">E17K<\/jats:styled-content>\n                    and\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">KIT<\/jats:styled-content>\n                    <\/jats:italic>\n                    <jats:styled-content style=\"fixed-case\">D816V<\/jats:styled-content>\n                    hotspot variants were each detected in one\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">IDH2<\/jats:styled-content>\n                    <\/jats:italic>\n                    \u2010mutated\n                    <jats:styled-content style=\"fixed-case\">SNUC<\/jats:styled-content>\n                    <jats:italic>.<\/jats:italic>\n                    The vast majority of\n                    <jats:styled-content style=\"fixed-case\">SNUCs<\/jats:styled-content>\n                    and variable proportions of other poorly\u2010differentiated sinonasal carcinomas may be amenable to\n                    <jats:styled-content style=\"fixed-case\">IDH2<\/jats:styled-content>\n                    \u2010targeted therapy. Copyright \u00a9 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley &amp; Sons, Ltd.\n                  <\/jats:p>","DOI":"10.1002\/path.4915","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T11:53:38Z","timestamp":1494503618000},"page":"400-408","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["Frequent\n                    <i>\n                      <scp>IDH2<\/scp>\n                    <\/i>\n                    <scp>R172<\/scp>\n                    mutations in undifferentiated and poorly\u2010differentiated sinonasal carcinomas"],"prefix":"10.1002","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4905-8946","authenticated-orcid":false,"given":"Snjezana","family":"Dogan","sequence":"first","affiliation":[{"name":"Department of Pathology Memorial Sloan Kettering Cancer Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J","family":"Chute","sequence":"additional","affiliation":[{"name":"Department of Pathology Cleveland Clinic  Cleveland OH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pathology Sunnybrook Health Sciences Centre  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan N","family":"Ptashkin","sequence":"additional","affiliation":[{"name":"Department of Pathology Memorial Sloan Kettering Cancer Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghu","family":"Chandramohan","sequence":"additional","affiliation":[{"name":"Department of Pathology Memorial Sloan Kettering Cancer Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacklyn","family":"Casanova\u2010Murphy","sequence":"additional","affiliation":[{"name":"Department of Pathology Memorial Sloan Kettering Cancer Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khedoudja","family":"Nafa","sequence":"additional","affiliation":[{"name":"Department of Pathology Memorial Sloan Kettering Cancer Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin A","family":"Bishop","sequence":"additional","affiliation":[{"name":"Department of Pathology The Johns Hopkins Hospital  Baltimore MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simion I","family":"Chiosea","sequence":"additional","affiliation":[{"name":"Department of Pathology University of Pittsburgh Medical Center  Pittsburgh PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B","family":"Stelow","sequence":"additional","affiliation":[{"name":"Department of Pathology University of Virginia Health System  Charlottesville VA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Ganly","sequence":"additional","affiliation":[{"name":"Department of Surgery Memorial Sloan Kettering Cancer Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G","family":"Pfister","sequence":"additional","affiliation":[{"name":"Department of Medicine Memorial Sloan Kettering Cancer Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Katabi","sequence":"additional","affiliation":[{"name":"Department of Pathology Memorial Sloan Kettering Cancer Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A","family":"Ghossein","sequence":"additional","affiliation":[{"name":"Department of Pathology Memorial Sloan Kettering Cancer Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F","family":"Berger","sequence":"additional","affiliation":[{"name":"Department of Pathology Memorial Sloan Kettering Cancer Center  New York NY USA"},{"name":"Human Oncology and Pathogenesis Program Memorial Sloan Kettering Cancer Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,6,9]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-198611000-00004"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1236165"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/0194599816670146"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2014.12.006"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw520"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808710"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.2913"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0386"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.3730"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-391748"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2015.05.005"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2016.239"},{"key":"e_1_2_6_14_1","unstructured":"DiNardoC SteinEM AltmanJK et al. AG\u2010221 an oral selective first\u2010in\u2010class potent inhibitor of the IDH2 mutant enzyme induced durable responses in a phase 1 study of IDH2 mutation\u2010positive advanced hematologic malignancies [abstract]. InProceedings of the 20th Congress of the European Hematology Association 11\u201314 June 2015 Vienna Austria. EHA: The Hague 2015; Abstract No P569."},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.11.015"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10860"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.226753.113"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.263145.115"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3391"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3307"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.806"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1754"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.4691"}],"container-title":["The Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpath.4915","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/pathsocjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/path.4915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:53:11Z","timestamp":1760957591000},"score":1,"resource":{"primary":{"URL":"https:\/\/pathsocjournals.onlinelibrary.wiley.com\/doi\/10.1002\/path.4915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,9]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1002\/path.4915"],"URL":"https:\/\/doi.org\/10.1002\/path.4915","archive":["Portico"],"relation":{},"ISSN":["0022-3417","1096-9896"],"issn-type":[{"value":"0022-3417","type":"print"},{"value":"1096-9896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,9]]},"assertion":[{"value":"2017-01-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-04-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-06-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}